Head-to-head · WeighScore
Nucific vs PrescribedRX
By GLP-1 ScorecardUpdated
Score comparison
PrescribedRX has the higher recorded score — 59/100 to 56.2/100.
PrescribedRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. PrescribedRX is a multi-condition telehealth brand (TRT, longevity, hair loss, sexual health and weight loss) that prescribes compounded GLP-1 injectables for weight loss: semaglutide at $140/month and tirzepatide at $199/month on a 3-month plan billed every three months.
Before you choose
Before comparing the headline prices, the Nucific review and the PrescribedRX review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Nucific vs RxSpan MD and PrescribedRX vs Synergy Rx compare each of them with another graded program, and the list of alternatives to Nucific ranks the programs closest to Nucific on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the HumeCare+ review covers one graded close to these two, at 58.6/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Nucific | PrescribedRX |
|---|---|---|
| WeighScore | 56.2/100 | 59/100 |
| Grade | C | C |
| Site position | #449 | #384 |
| Semaglutide | As low as $117/mo (compounded) | $140/mo (3-month plan, $420 every 3 months; compounded) |
| Tirzepatide | As low as $139/mo (compounded) | $199/mo (3-month plan, $597 every 3 months; compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Founder is named and credentialed: Dr. Amy Lee, MD, triple board-certified in Internal Medicine, Obesity Medicine and Clinical Nutrition
- Cites SURMOUNT-1 properly, naming the trial, the 20.9% average and the Jastreboff NEJM 2022 source
- Discloses that featured patients were compensated for their time
- Labels its NAD+ decline chart as illustrative and not a measurement, with an unusually careful methodology note
- Offers compounded, microdosed and brand-name Ozempic and Zepbound in one catalog
What to consider
- No price is published anywhere; every option is gated behind a three-minute quiz
- The LegitScript badge is a self-hosted image with generic alt text rather than the issued embed, so the certification could not be verified
- A BBB Accredited A+ claim is displayed without a link to the BBB profile
- No state list and no named pharmacy, only licensed U.S. pharmacies
- Before-and-after photographs are used alongside compensated testimonials
Strengths
- Compounded semaglutide ($140/mo) and tirzepatide ($199/mo) injectables on a 3-month plan, billed $420 and $597 every three months
- Clear, upfront plan pages showing monthly and multi-month pricing with no surprise fees
- Care from licensed US providers with monthly home delivery and ongoing dose support
- Bilingual English/Spanish site and a broader telehealth menu (TRT, longevity, hair, sexual health) for people who want more than weight loss
What to consider
- Doesn't publish the states it serves — you only learn eligibility after starting the intake
- Compounding pharmacies aren't named on the site
- Only a 3-month plan is shown; no month-to-month option is published
- Compounded semaglutide and tirzepatide injectables only — no brand-name or oral options
- Self-hosted affiliate program (not a vetted network); Florida/Palm Beach framing suggests a regional lean
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.